Report on operations in the year ended April 30, 2004

Report on operations in the year ended April 30, 2004 · Profit after taxes increased to SEK 248 M (234). Earnings per share before dilution in-creased to SEK 7.63 (7.29) and after dilution to SEK 7.63 (7.14). · Operating profit amounted to SEK 306 M (323) and the operating margin was 11 percent (12). · Cash flow after investments rose sharply to SEK 363 M (288). · Order bookings rose 2 percent to SEK 3,262 M (3,186). At fixed exchange rates, order bookings increased 12 percent. Order bookings in the fourth quarter were SEK 1,119 M (974), up 15 percent. · The order backlog at April 30, 2004 amounted to SEK 2,728 M (2,411), a record high level. · Net sales rose 4 percent to SEK 2,900 M (2,781). At fixed exchange rates, net sales in-creased 14 percent. · The Board proposes that the Annual General Meeting provides authorization for buy-back of shares in Elekta AB corresponding to a maximum of 10 percent of the total number of shares outstanding. For full version, please see enclosed PDF file. For additional information, contact: Peter Ejemyr, Group VP Corporate Communications, Elekta AB (publ) Tel. +46-8-587 254 00 or +46-733-611 000 Further information on Elekta is available at: www.elekta.com ------------------------------------------------------------ This information was brought to you by Waymaker http://www.waymaker.net The following files are available for download: http://www.waymaker.net/bitonline/2004/06/15/20040615BIT20750/wkr0006.pdf Reports on operations in the year ended April 30, 2004

About Us

For almost five decades, Elekta has been a leader in precision radiation medicine. Our nearly 4,000 employees worldwide are committed to ensuring everyone in the world with cancer has access to – and benefits from – more precise, personalized radiotherapy treatments. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm Exchange. Visit elekta.com or follow @Elekta on Twitter.

Subscribe

Documents & Links